@FiercePharma: MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report from FierceVaccines | Follow @FiercePharma
@CarlyHFierce: ICYMI: Actavis working to add Allergan CEO Pyott to board: Reuters. Story | Follow @CarlyHFierce
> The EU has approved Novartis' ($NVS) new-age psoriasis therapy, Cosentyx. More
> Merck ($MRK) is funding tests of lower Zilmax doses as it looks to reintroduce the controversial cattle feed additive to the market. Report
> Bayer has updated its Xarelto label in Europe to include guidance for use in patients with atrial fibrillation undergoing cardioversion. Release
> An ex-priest who volunteered for an early trial of Novartis' Jakavi is suing the company after suffering "catastrophic" brain damage. More
> The FDA has promoted Kathleen Uhl from acting to permanent director of its Office of Generic Drugs. More
> India's Alkem Labs has appointed banks for an IPO of up to $291 million. Report
> The FDA has released new recommendations for makers of psychoactive drugs--including sleep aids--to ensure the treatments' lingering effects don't cause car accidents. More
Medical Device News
@FierceMedDev: ICYMI: Researchers develop needle-free temporary tattoo for glucose monitoring. Article | Follow @FierceMedDev
@VarunSaxena2: Piramal buys Coldstream - The Hindu. More | Follow @VarunSaxena2
@EmilyWFierce: Carmat notches a win as artificial heart patient returns home. More | Follow @EmilyWFierce
> FDA to avoid regulating most wearables, seeking to reduce medical device regulation overall. News
> India opens medical device industry to foreign direct investment. Report
Biotech News
@FierceBiotech: ICYMI: Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms. Report | Follow @FierceBiotech
@JohnCFierce: Alzheimer's investigators open a new front in BACE1 war. More from FierceBiotechResearch | Follow @JohnCFierce
@DamianFierce: A CF patient taking $VRTX's Kalydeco will be a guest of Michelle Obama at the State of the Union tonight. More | Follow @DamianFierce
> Actavis, Richter tout new PhIII data for their tarnished schizophrenia drug. Article
> CytRx surges after FDA lifts a partial hold on late-stage cancer drug. Story
Biotech IT News
> Personalis raises $33M to scale up pharma-facing genomics operation. Report
> 10X Genomics exits stealth mode with $80M, plan to improve Illumina tech. News
> Novartis teams with Qualcomm on $100M digital health fund. Item
> Genentech teams with Venter's HLI as Roche group continues genomics push. Story
> 23andMe inks Pfizer deal, eyes 2015 resolution of FDA dispute. Article
CRO News
> Clinipace banks $50M to scout for more deals. Story
> Evotec strikes an R&D deal focused on addiction. More
> AMRI inks a 10-year NIH deal with $37M on the line. News
> Ergomed posts a big year with more in store for 2015. Article
> Sanofi taps Catalent for antibody R&D. Report
Animal Health News
> Annual sales of animal health products stable at $7.5B. Item
> China bans import of U.S. poultry products on avian flu fear. Report
> Microbiome dealmaking hits animal health with Metanome-Companion PBx linkup. More
> PetMed's sales fall but profit margins expand on rising demand for pricier products. Story
> Zoetis, IDEXX, Schein among animal health scene-stealers at JP Morgan confab. Article
Biotech Research News
> Genetic error highlights a new approach to Fragile X syndrome. Report
> Microbiome research opens a new pathway for autoimmune disease. Article
> Tracking tech illuminates T cells for immuno-oncology research. Item
> Michigan investigators finger ATDC gene for aggressive pancreatic cancer. Story
> Alzheimer's investigators open a new front in BACE1 war. More
Pharma Manufacturing News
> Actavis recalling 65,000 bottles of generic seizure drug. News
> FDA raises issues with another Apotex plant. Article
> India makes move to reduce reliance on Chinese APIs. Item
> Boehringer Ingelheim picks up contract work for Sanofi mAbs. News
> India's Piramal says it will snatch up university CDMO for its injectables skills. Report
And Finally... With the flu vaccine falling short this season, the U.S. death toll is rising. Report